Anna Furlan

5PUBLICATIONS
41CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 18, 2026
Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

|Jan 15, 2026
Imaging in Plasma-Cell Neoplasms: Italian Experts' Recommendations.

Alessandro Corso, Monia Marchetti, Monica Galli

|Feb 13, 2025
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts.

Mattia D'Agostino, Marina Martello, Lorenzo De Paoli

|Apr 01, 2024
A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.

Anna Furlan, Michele Cea, Laura Pavan

|Nov 09, 2023
Improved efficiency of daratumumab treatment of multiple myeloma adopting the subcutaneous route: A micro-costing analysis in three Italian hematology centers.

Lorenzo Pradelli, Massimo Massaia, Elisabetta Todisco

Pageof 1

Frequent Collaborators

2 joint publications

Massimo Gentile

2 joint publications

Lorenzo De Paoli

2 joint publications

Silvia Mangiacavalli

2 joint publications

Elena Zamagni